On July 9th, CHERVON (02285) spent about HK$2.8409 million to repurchase 150,000 shares.

17:34 09/07/2026

Spring Peak Holdings (02285) announced that on July 9, 2026, the company repurchased approximately 284.09 million Hong Kong dollars to buy back 150,000 shares at a repurchase price of 18.49 to 19.39 Hong Kong dollars per share.

CHERVON (02285) announced that on July 9, 2026, the company will spend approximately 2.8409 million Hong Kong dollars to repurchase 150,000 shares at a repurchase price of 18.49 to 19.39 Hong Kong dollars per share.

IMMUNEONCO-B(01541) spent HKD 221,600 to repurchase 63,600 shares on July 9th.

DMALL (02586) spent 3.0854 million Hong Kong dollars on buying back 506,700 shares on July 9th.

MICOT PHARMA-B(02335): The Phase II clinical trial of MT1002 for anticoagulation in hemodialysis patients has completed the enrollment of the first patient.

IMMUNEONCO-B(01541) spent HKD 221,600 to repurchase 63,600 shares on July 9th.

DMALL (02586) spent 3.0854 million Hong Kong dollars on buying back 506,700 shares on July 9th.

MICOT PHARMA-B(02335): The Phase II clinical trial of MT1002 for anticoagulation in hemodialysis patients has completed the enrollment of the first patient.